AstraZeneca Pharma India Limited — Updates, 17-11-2025: General Updates
17-11-2025 | 03:42 pm
17-11-2025 | 03:42 pm
AstraZeneca partners with Sun Pharma for India distribution of Sodium Zirconium Cyclosilicate (SZC), a Hyperkalaemia treatment. AstraZeneca will receive Rs. 26 Cr (upfront + milestones) from Sun Pharma. This deal expands market access for the innovative drug.
No comments yet. Be the first to comment!
